Lawson Macartney is a director of Viking Therapeutics, Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Viking Therapeutics, Inc.
4 Jan 24
4
Viking Therapeutics, Inc.
18 May 23
144
Viking Therapeutics, Inc.
16 May 23
4
Viking Therapeutics, Inc.
24 Apr 23
144
Viking Therapeutics, Inc.
24 Apr 23
4
Viking Therapeutics, Inc.
18 Apr 23
144
Viking Therapeutics, Inc.
17 Apr 23
4
Viking Therapeutics, Inc.
4 Jan 23
4
Viking Therapeutics, Inc.
5 Jan 22
4
Viking Therapeutics, Inc.
6 Jan 21
Recent insider trades
| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 2 Jan 24 | VKTX Viking Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 18.28 | 32,000 | 584.96 k | 32,000 |
| 16 May 23 | VKTX Viking Therapeutics | Common Stock, par value $0.00001 per share | Sell | Dispose S | No | Yes | 24 | 16,000 | 384.00 k | 47,965 |
| 16 May 23 | VKTX Viking Therapeutics | Common Stock, par value $0.00001 per share | Option exercise | Acquire M | No | Yes | 1.19 | 16,000 | 19.04 k | 63,965 |
| 16 May 23 | VKTX Viking Therapeutics | Stock Option Common Stock | Option exercise | Dispose M | No | Yes | 1.19 | 16,000 | 19.04 k | 0 |